Seagate Technology Holdings PLC R&D increased by 3.7% to $194.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 7.8%, from $180.00M to $194.00M. Over 4 years (FY 2021 to FY 2025), R&D shows a downward trend with a -5.4% CAGR.
Higher spending signals a commitment to innovation and future product launches, whereas significant cuts may indicate a shift toward short-term profitability.
Research and development expenses represent the costs incurred to discover new products, improve existing technologies,...
Highly comparable across pharmaceutical and medical device peers, where R&D intensity is a key metric for long-term valuation.
research_and_development| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $232.00M | $233.00M | $228.00M | $233.00M | $247.00M | $234.00M | $200.00M | $191.00M | $172.00M | $171.00M | $161.00M | $164.00M | $158.00M | $181.00M | $184.00M | $180.00M | $179.00M | $186.00M | $187.00M | $194.00M |
| QoQ Change | — | +0.4% | -2.1% | +2.2% | +6.0% | -5.3% | -14.5% | -4.5% | -9.9% | -0.6% | -5.8% | +1.9% | -3.7% | +14.6% | +1.7% | -2.2% | -0.6% | +3.9% | +0.5% | +3.7% |
| YoY Change | — | — | — | — | +6.5% | +0.4% | -12.3% | -18.0% | -30.4% | -26.9% | -19.5% | -14.1% | -8.1% | +5.8% | +14.3% | +9.8% | +13.3% | +2.8% | +1.6% | +7.8% |